Alexander Mayweg

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Alexander Mayweg

Earlier roles on record: Board Member at Black Diamond Therapeutics, Inc. (BDTX) until April 10, 2024. Black Diamond Therapeutics, Inc. reported in an 8-K filed April 11, 2024 that Alexander Mayweg resigned as Board of Directors, effective April 10, 2024.

“On April 10, 2024, Alexander Mayweg, Ph.D. resigned from the Board of Directors (the "Board") of Black Diamond Therapeutics, Inc. (the "Company").”

Black Diamond Therapeutics, Inc. Form 8-K, filed April 11, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Alexander Mayweg's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Black Diamond Therapeutics, Inc. (BDTX)
Board Member

Proxy statement

Start not stated–2024-04-10
Black Diamond Therapeutics, Inc. (BDTX)
Board Member

Proxy statement

Start not stated–2024-04-10

Company network

Recorded roles and call appearances connecting this person to public companies.

Black Diamond Therapeutics, Inc.

BDTX

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Board of Directors Black Diamond Therapeutics, Inc. (BDTX)
2024-04-10